Conversely, maintained action of Foxo1 was reported to protect against the disruption of lipid metabolism characteristic of cancer [50], and this was the case in our hSDC1+/+ DEN tumors where, in contrast to the WT DEN tumors, expression of Foxo1 remained unaltered compared to untreated controls. The gene discussed is FOXO1; the disease is cancer.